Loading…

POSTER: MM-514 Vactosertib, a Novel Transforming Growth Factor Beta (TGFß) Type I Receptor Kinase Inhibitor, Improves T-Cell Fitness: A Single-Arm, Phase Ib Trial in Relapsed or Refractory Multiple Myeloma (RRMM)

Saved in:
Bibliographic Details
Published in:Clinical lymphoma, myeloma and leukemia myeloma and leukemia, 2023-09, Vol.23, p.S226-S226
Main Authors: Malek, Ehsan, Rana, Priyanka, Daunov, Michael, Miyagi, Masaru, Ignatz-Hoover, James, Metheny, Leland, Driscoll, James
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2152-2650
2152-2669
DOI:10.1016/S2152-2650(23)00865-0